From StructYou came from “Tenax: $610M market cap, $0.00 in sales”Back to the brief ↗Feed / TENX

Tenax Therapeutics, Inc.

TENX

Healthcare · 15.56 -2.7% today

Jodie read · what matters now

Market values Tenax at $610.0M while the company reported $0.00 in revenue for both 2024 and 2025; shares closed at $15.55 on July 14, down 2.7%.

The story is only the start. Jodie keeps watching the filing evidence, the companies connected to TENX, and whether its market group begins moving.

Latest story10-Q · Jul 31, 2026Read on Struct ↗

Disclosed connectionsNo verified linksBuilt from company filings

Organic co-movement groupRare Disease Biotech · ParticipantDiscovered from trading behaviour, not sector labels · Open group →

Who this business touches

The relationships behind TENX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Filing peers

No filing peers are available for this name yet.

You can see the shape of the network here. Pro opens the original filing receipts, and alerts when connected names begin moving. See Pro →

What is moving around it

Live connections

TENX is currently a Participant in the organic co-movement group Rare Disease Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.

Theme membership history

No durable theme membership has been observed for this name yet.